Canadian hashish producer Tilray is providing dronabinol within the German medical hashish market, in accordance to a discover within the German commerce publication Apotheke Ad-Hoc.

Tilray’s dronabinol is plant-derived – like most, if not all, of the dronabinol obtainable in Germany.

The discover says Tilray sources the dronabinol from producer Echo Pharmaceuticals within the Netherlands.

Tilray has been providing full-spectrum extracts in Germany for a number of years.

Based on earlier monetary disclosures, Smiths Falls, Ontario-based Canopy Growth stays the chief of the dronabinol sector in Germany thanks to its acquisition of C3 Cannabinoid Compound Co. in 2019 from Bionorica.

The class is changing into more and more aggressive.

In April, Berlin-based Cantourage began providing pharmacies dronabinol imported from Israel.

Other corporations providing dronabinol in Germany to pharmacies embrace:

  • ADREXpharma.
  • Caesar & Loretz.
  • Fagron.

The dronabinol class stays important within the total German market.

But as a result of it’s thought-about an lively pharmaceutical ingredient (API), model differentiation is tougher than, as an illustration, flower.

Doctors in Germany usually don’t prescribe a particular model of dronabinol; they prescribe a particular formulation with dronabinol, and it’s up to pharmacies to supply the API from a wholesaler of their choice.

Source link